The hypertensive psychiatric patient: pharmacologic problems.
Psychiatric symptoms secondary to antihypertensive drugs and adverse drug interactions between antihypertensive and psychotropic drugs are described. Recommendations are made concerning the drug therapy of the hypertensive psychiatric patient.
D000959:Antihypertensive Agents / Q000009:adverse effects*; D003000:Clonidine / Q000009:adverse effects; D003863:Depression / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy; D004232:Diuretics / Q000009:adverse effects; D004347:Drug Interactions; D006145:Guanethidine / Q000009:adverse effects; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D008094:Lithium / Q000378:metabolism; D001523:Mental Disorders / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*; D008750:Methyldopa / Q000009:adverse effects; D011433:Propranolol / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000009:adverse effects*; D012110:Reserpine / Q000009:adverse effects
D000959:Antihypertensive Agents; D004232:Diuretics; D011619:Psychotropic Drugs; D006830:Hydralazine; D008750:Methyldopa; D012110:Reserpine; D008094:Lithium; D011433:Propranolol; D003000:Clonidine; D006145:Guanethidine